Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. (Nasdaq: VITL) is a Certified B Corporation and Delaware public benefit corporation that focuses on pasture-raised eggs and egg-based foods such as shell eggs, butter, hard-boiled eggs, and liquid whole eggs. As a publicly traded company, Vital Farms files regular reports and current reports with the U.S. Securities and Exchange Commission (SEC), providing detailed information on its financial performance, risks, governance, and strategic initiatives.
On this page, you can review Vital Farms’ SEC filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its business model, farm network, product categories, and risk factors related to supply, consumer demand, agricultural disease, regulation, and macroeconomic conditions. These filings also discuss its status as a public benefit corporation, its stakeholder-focused objectives, and its emphasis on humane treatment of farm animals and sustainable farming practices.
Current reports on Form 8-K offer more immediate updates. Recent 8-K filings have covered quarterly financial results, long-term net revenue targets, and governance matters such as the appointment of a new independent director and the frequency of advisory Say-on-Pay votes. An amended 8-K explains the company’s decision to hold non-binding advisory votes on executive compensation annually, following stockholder preferences.
Stock Titan’s platform enhances access to these documents with AI-powered summaries that explain key sections of Vital Farms’ filings in plain language. Investors can quickly understand highlights from lengthy 10-K and 10-Q reports, see what management disclosed in 8-K earnings releases, and track governance items without reading every page. Real-time updates from EDGAR ensure that new filings appear promptly, while AI-generated overviews help readers identify significant changes, recurring themes, and references to long-term targets and capital projects.
For users monitoring insider and governance activity, this page also centralizes access to forms and disclosures related to directors and executive compensation policies as referenced in Vital Farms’ filings.
Vital Farms furnished an 8-K announcing its financial results for the fiscal quarter ended September 28, 2025. The company shared the results via a press release attached to the filing.
The press release is included as Exhibit 99.1 and is incorporated by reference. The information in this report, including Exhibit 99.1, is furnished and not deemed filed under the Exchange Act.
Vital Farms director and CEO Russell Diez-Canseco reported two sales of company common stock on 10/08/2025 under a Rule 10b5-1 trading plan. The filings show 5,263 shares sold at a weighted average price of $44.11 and 4,404 shares sold at a weighted average price of $44.72, a total of 9,667 shares disposed. After the transactions the reporting person beneficially owned 670,513 shares following the first sale and 666,109 shares following the second sale, as reported. The Form 4 states the 10b5-1 plan was adopted on 05/12/2025 and that the sales occurred in multiple transactions within the disclosed price ranges.
Matthew Ohayer, Executive Chairperson, Director and 10% owner of Vital Farms, Inc. (VITL), reported multiple open-market sales of common stock on 10/01/2025 completed under a Rule 10b5-1 trading plan adopted on March 14, 2025. The filing shows three sales: 600 shares at $38.17, 23,536 shares at a weighted average of $39.98, and 10,864 shares at a weighted average of $40.63, for a total of 35,000 shares sold. Following these transactions, the reporting person’s direct beneficial ownership is reported as 6,447,070 shares. The filing also discloses 716,000 shares held by a former spouse over which the reporting person has sole voting control but no pecuniary interest. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Reena Chauhan Van Hoven, Chief People Officer of Vital Farms, Inc. (VITL), reported a routine share withholding transaction on 09/16/2025. The Form 4 shows 344 shares of Vital Farms common stock were disposed of under code F(1) at an indicated price of $47.05 per share, with the filer noting the shares were withheld to satisfy a withholding tax obligation. After this transaction the reporting person beneficially owned 10,765 shares, held directly.
The form is signed by an attorney-in-fact on behalf of the reporting person on 09/18/2025. No derivative securities or other transactions are reported on this Form 4.
Vital Farms insider Matthew Ohayer reported a sale of Common Stock on 09/04/2025. The filing shows 100,000 shares were sold at a weighted-average price of $50.96, with individual trade prices ranging from $50.75 to $51.21. After the reported disposition the filing shows Mr. Ohayer beneficially owns 6,482,070 shares directly and an additional 716,000 shares indirectly (held by his former spouse), over which he has sole voting control but no pecuniary interest. The Form 4 was signed by an attorney-in-fact on 09/08/2025 and includes an undertaking to provide trade-by-trade price details on request.
Vital Farms, Inc. (VITL) filing: insider sale notice. The document is a Form 144 reporting a proposed sale of 100,000 common shares through Morgan Stanley Smith Barney on 09/04/2025 with an aggregate market value of $5,096,010.00. The shares were originally acquired as founder stock on 01/06/2015 and paid in cash. The filer previously sold a total of 310,000 shares across multiple dates in the prior three months, generating gross proceeds shown per sale. The filing states the seller represents no undisclosed material adverse information about the issuer.
Joseph Michael Holland, identified as Chief Supply Chain Officer of Vital Farms, Inc. (VITL), reported a withholding-related disposal of company stock on 09/02/2025. The Form 4 shows 412 shares were disposed under code F(1) to satisfy withholding tax obligations at a reported price of $51.90 per share. After the transaction, the filing reports 11,451 shares beneficially owned directly by the reporting person. The form was signed by an attorney-in-fact on 09/04/2025. No derivative transactions or other securities classes are disclosed in this filing.
Matthew Ohayer, Executive Chairperson, Director and reported 10% owner of Vital Farms, Inc. (VITL), disclosed multiple sales of Common Stock. On 08/29/2025 he sold 100,000 shares at a weighted average price of $51.13, leaving 6,727,070 shares beneficially owned. On 09/02/2025 he sold 100,000 shares at $51.98 and additional lots of 20,559 and 24,441 shares at weighted prices of $51.52 and $52.39 respectively, with reported post-sale ownership levels of 6,627,070, 6,606,511 and 6,582,070 shares. An indirect holding of 716,000 shares is reported as held by a former spouse over which he has sole voting control but no pecuniary interest. Some September sales were made pursuant to a Rule 10b5-1 plan adopted March 14, 2025. The Form 4 was signed by an attorney-in-fact on 09/03/2025.
Insider sale notice for VITL: This Form 144 shows proposed sale of 100,000 common shares on or about 09/02/2025 through Morgan Stanley Smith Barney (NASDAQ). The filer acquired the shares as founder stock on 01/06/2015 and paid cash. The issuer has 44,685,980 shares outstanding, making the proposed block ~0.22% of outstanding shares. The filing also lists prior sales by the same person totaling 210,000 shares between 06/13/2025 and 08/29/2025, with gross proceeds reported for each trade. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Vital Farms insider sale notice. This Form 144 shows that Matthew O'Hayer, identified as the person for whose account the securities are to be sold, intends to sell 100,000 common shares through Morgan Stanley Smith Barney LLC on or about 08/29/2025 on NASDAQ. The shares were acquired as founder stock on 01/06/2015 and payment was in cash. The filing also lists multiple recent sales by the same person during June–August 2025 totaling 110,000 shares, with individual gross proceeds reported for each trade. The filing includes a standard representation that the seller is not aware of undisclosed material adverse information.